Login / Signup

Dihydroergotamine mesylate nasal spray: an acute treatment option for migraine in adults.

Marcello SilvestroIlaria OrologioAlessandro TessitoreFrancesca TrojsiGioacchino TedeschiAntonio Russo
Published in: Expert review of neurotherapeutics (2024)
DHE nasal spray could be considered as rescue treatment in patients who have failed other symptomatic therapeutic strategies. Nevertheless, in the perspective of tailored therapy, the intranasal route of administration and the consequent rapid onset of action may represent benefits putatively making DHE a treatment of choice for challenging migraine attacks such as those with nocturnal onset or quickly reaching the climax of both headache and neurovegetative associated symptoms.
Keyphrases
  • liver failure
  • obstructive sleep apnea
  • combination therapy
  • replacement therapy
  • mesenchymal stem cells
  • drug induced
  • sleep apnea